全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

儿童重症肺炎的诊治进展
Advances in Diagnosis and Treatment of Severe Pneumonia in Children

DOI: 10.12677/acm.2024.14102732, PP. 811-816

Keywords: 儿童,重症肺炎,诊断,治疗
Children
, Severe Pneumonia, Diagnosis, Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

肺炎是全球5岁以下儿童死亡的重要原因,重症肺炎可引起严重的通换气功能障碍及肺部内外并发症,具有较高的死亡率。近年来,细菌抗生素耐药率的不断上升,给临床治疗带来了极大挑战,合理选择抗生素变得尤为重要。本文就儿童重症肺炎的诊治及细菌耐药现状作一综述,以期为重症肺炎患儿的临床诊疗和临床药物的合理使用提供帮助。
Pneumonia is an important cause of death in children under 5 years old worldwide. Severe pneumonia is prone to severe ventilation dysfunction and internal and external pulmonary complications, with a high mortality rate. In recent years, the increasing rate of bacterial antibiotic resistance has brought great challenges to clinical treatment, and the rational selection of antibiotics has become particularly important. This article reviews the diagnosis and treatment of severe pneumonia in children and the current status of bacterial resistance, in order to provide help for the clinical diagnosis and treatment of children with severe pneumonia and the rational use of clinical drugs.

References

[1]  Liu, L., Oza, S., Hogan, D., Chu, Y., Perin, J., Zhu, J., et al. (2016) Global, Regional, and National Causes of Under-5 Mortality in 2000-15: An Updated Systematic Analysis with Implications for the Sustainable Development Goals. The Lancet, 388, 3027-3035.
https://doi.org/10.1016/s0140-6736(16)31593-8
[2]  Walker, C.L.F., Rudan, I., Liu, L., Nair, H., Theodoratou, E., Bhutta, Z.A., et al. (2013) Global Burden of Childhood Pneumonia and Diarrhoea. The Lancet, 381, 1405-1416.
https://doi.org/10.1016/s0140-6736(13)60222-6
[3]  Bhuiyan, M.U., Snelling, T.L., West, R., Lang, J., Rahman, T., Granland, C., et al. (2018) The Contribution of Viruses and Bacteria to Community-Acquired Pneumonia in Vaccinated Children: A Case-Control Study. Thorax, 74, 261-269.
https://doi.org/10.1136/thoraxjnl-2018-212096
[4]  Ferreira-Coimbra, J., Sarda, C. and Rello, J. (2020) Burden of Community-Acquired Pneumonia and Unmet Clinical Needs. Advances in Therapy, 37, 1302-1318.
https://doi.org/10.1007/s12325-020-01248-7
[5]  Huemer, M., Mairpady Shambat, S., Brugger, S.D. and Zinkernagel, A.S. (2020) Antibiotic Resistance and Persistence—Implications for Human Health and Treatment Perspectives. EMBO Reports, 21, e51034.
https://doi.org/10.15252/embr.202051034
[6]  Qian, C., Chen, Q., Lin, W., Li, Z., Zhu, J., Zhang, J., et al. (2024) Incidence of Community-Acquired Pneumonia among Children under 5 Years in Suzhou, China: A Hospital-Based Cohort Study. BMJ Open, 14, e078489.
https://doi.org/10.1136/bmjopen-2023-078489
[7]  World Health Organization (2024) Global Health Estimates 2021: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2021.
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
[8]  Bender, R.G., Sirota, S.B., Swetschinski, L.R., Dominguez, R.V., Novotney, A., Wool, E.E., et al. (2024) Global, Regional, and National Incidence and Mortality Burden of Non-COVID-19 Lower Respiratory Infections and Aetiologies, 1990-2021: A Systematic Analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases, 24, 974-1002.
https://doi.org/10.1016/s1473-3099(24)00176-2
[9]  Chen, L., Miao, C., Chen, Y., Han, X., Lin, Z., Ye, H., et al. (2021) Age-Specific Risk Factors of Severe Pneumonia among Pediatric Patients Hospitalized with Community-Acquired Pneumonia. Italian Journal of Pediatrics, 47, Article No. 100.
https://doi.org/10.1186/s13052-021-01042-3
[10]  曹园园, 赵丽, 缪红军. 急诊肺炎患儿进展为重症肺炎的危险因素分析[J]. 中华危重病急救医学, 2023, 35(5): 528-532.
[11]  倪鑫. 儿童社区获得性肺炎诊疗规范(2019年版) [J]. 全科医学临床与教育, 2019, 17(9): 771-777.
[12]  邹映雪, 张旭冉. 儿童重症肺炎生物标志物研究及应用进展[J]. 中国实用儿科杂志, 2022, 37(2): 92-96.
[13]  邹映雪, 赵顺英, 刘瀚旻. 儿童重症肺炎临床预警及早期决策专家共识[J]. 中国实用儿科杂志, 2023, 38(3): 177-182.
[14]  章曼曼, 林立, 李昌崇. 儿童社区获得性肺炎病原及混合感染研究进展[J]. 中国实用儿科杂志, 2019, 34(12): 1034-1037.
[15]  Liu, J., Zhao, F., Lu, J., Xu, H., Liu, H., Tang, X., et al. (2019) High Mycoplasma Pneumoniae Loads and Persistent Long-Term Mycoplasma Pneumoniae DNA in Lower Airway Associated with Severity of Pediatric Mycoplasma Pneumoniae Pneumonia. BMC Infectious Diseases, 19, Article No. 1045.
https://doi.org/10.1186/s12879-019-4667-y
[16]  中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 新发传染病电子杂志, 2024, 9(1): 73-79.
[17]  Gu, W., Miller, S. and Chiu, C.Y. (2019) Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annual Review of Pathology: Mechanisms of Disease, 14, 319-338.
https://doi.org/10.1146/annurev-pathmechdis-012418-012751
[18]  宏基因组分析和诊断技术在急危重症感染应用专家共识组. 宏基因组分析和诊断技术在急危重症感染应用的专家共识[J]. 中华急诊医学杂志, 2019, 28(2): 151-155.
[19]  Duval, R.E., Grare, M. and Demoré, B. (2019) Fight against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria. Molecules, 24, Article 3152.
https://doi.org/10.3390/molecules24173152
[20]  Fu, P., Xu, H., Jing, C., Deng, J., Wang, H., Hua, C., et al. (2021) Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020. Microbiology Spectrum, 9, e0028321.
https://doi.org/10.1128/spectrum.00283-21
[21]  全国细菌耐药监测网. 2018至2022年0-14岁患儿细菌耐药监测研究[J]. 中华儿科杂志, 2023, 61(11): 1001-1010.
[22]  Mai, W., Liu, Y., Meng, Q., Xu, J. and Wu, J. (2023) Bacterial Epidemiology and Antimicrobial Resistance Profiles of Respiratory Specimens of Children with Pneumonia in Hainan, China. Infection and Drug Resistance, 16, 249-261.
https://doi.org/10.2147/idr.s397513
[23]  中华人民共和国国家健康委员会. 流行性感冒诊疗方案(2018年版修订版) [J]. 中华临床感染病杂志, 2019, 12(1): 1-5.
[24]  国家呼吸系统疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组, 中国医师协会呼吸医师分会儿科呼吸工作委员会, 等. 儿童呼吸道合胞病毒感染诊断、治疗和预防专家共识[J]. 中华实用儿科临床杂志, 2020, 35(4): 241-250.
[25]  中华人民共和国国家卫生健康委员会国家中医药管理局. 儿童腺病毒肺炎诊疗规范(2019年版) [J]. 中华临床感染病杂志, 2019(3): 161-166.
[26]  Pitre, T., Abdali, D., Chaudhuri, D., Pastores, S.M., Nei, A.M., Annane, D., et al. (2023) Corticosteroids in Community-Acquired Bacterial Pneumonia: A Systematic Review, Pairwise and Dose-Response Meta-Analysis. Journal of General Internal Medicine, 38, 2593-2606.
https://doi.org/10.1007/s11606-023-08203-6
[27]  Littorin, N., Rünow, E., Ahl, J., Resman, F. and Riesbeck, K. (2021) Decreased Prevalence of Moraxella Catarrhalis in Addition to Streptococcus pneumoniae in Children with Upper Respiratory Tract Infection after Introduction of Conjugated Pneumococcal Vaccine: A Retrospective Cohort Study. Clinical Microbiology and Infection, 27, 630.e1-630.e6.
https://doi.org/10.1016/j.cmi.2020.04.033
[28]  Lu, E., Chen, H., Zhao, H. and Ozawa, S. (2021) Health and Economic Impact of the Pneumococcal Conjugate Vaccine in Hindering Antimicrobial Resistance in China. Proceedings of the National Academy of Sciences, 118, e2004933118.
https://doi.org/10.1073/pnas.2004933118
[29]  Root-Bernstein, R. (2021) Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines, 9, Article 474.
https://doi.org/10.3390/vaccines9050474

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133